LYKALABS — Lyka Labs Balance Sheet
0.000.00%
- IN₹4.00bn
- IN₹4.28bn
- IN₹1.11bn
- 70
- 11
- 33
- 29
Annual balance sheet for Lyka Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 123 | 81.4 | 188 | 143 | 81.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 81.3 | 87.4 | 185 | 202 | 314 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 359 | 291 | 522 | 442 | 507 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 891 | 837 | 856 | 637 | 688 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,002 | 1,900 | 1,856 | 1,515 | 1,567 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 663 | 492 | 994 | 326 | 376 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,145 | 2,158 | 1,723 | 1,061 | 886 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -143 | -258 | 133 | 454 | 682 |
Total Liabilities & Shareholders' Equity | 2,002 | 1,900 | 1,856 | 1,515 | 1,567 |
Total Common Shares Outstanding |